针刺三个鼻部穴位联合穴位贴敷治疗常年性变应性鼻炎的多中心随机对照试验方案
本方案为多中心、单盲、随机对照试验,计划纳入120例常年性变应性鼻炎患者,比较针刺三个鼻部穴位联合穴位贴敷(AAP)与非经穴针刺联合假穴位贴敷的疗效。主要结局为4周治疗结束时总鼻症状评分较基线的变化,次要结局包括视觉模拟量表及非鼻症状评分在治疗第2、4周及治疗后1、3、6个月的变化,并检测外周血IL-4、IL-5、IL-6、IL-8、IL-10水平及记录不良反应。
要点
- 针刺EX-HN3、LI20、EX-HN8每周3次共12次,联合DU14、BL13、EX-BI、RN22穴位贴敷。
- 主要结局为4周治疗结束时总鼻症状评分较基线的变化。
- 次要结局包括视觉模拟量表及非鼻症状评分在治疗第2、4周及治疗后1、3、6个月的变化。
核心结论
- 该试验旨在评估针刺三个鼻部穴位联合穴位贴敷相比非经穴针刺联合假穴位贴敷治疗常年性变应性鼻炎的疗效,尤其关注长期效果。
研究设计与样本
- 多中心、单盲、随机对照试验方案,计划纳入120例常年性变应性鼻炎患者,随机分为治疗组和对照组。
- 随机化由专门指定的研究者负责,试验设计基于CONSORT 2010指南和STRICTA标准。
主要发现
- 原文为试验方案,尚未报告结果。
关键数值与推荐
- 治疗组:针刺EX-HN3、LI20、EX-HN8每周3次共12次,并贴敷DU14、BL13、EX-BI、RN22;对照组:假穴位贴敷。
- 主要结局:4周治疗结束时总鼻症状评分较基线的变化。
- 次要结局:视觉模拟量表及总非鼻症状评分在治疗第2、4周及治疗后1、3、6个月较基线的变化。
- 检测外周血IL-4、IL-5、IL-6、IL-8、IL-10水平,观察并记录治疗相关副作用。
临床怎么用
- 若试验证实有效,可为针刺三个鼻部穴位联合穴位贴敷治疗常年性变应性鼻炎提供高质量证据并改善临床推广。
局限性
- 原文未报告研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many studies have shown the potential therapeutic effect of acupuncture on allergic rhinitis. Most of these studies were limited by low-quality evidence. Preliminary experiments showed that the use of acupuncture at three nasal acupoints plus acupoint application (AAP) achieves a more persistent effect in the treatment of perennial allergic rhinitis than acupuncture alone. In this study, a multicenter, single-blind, randomized controlled trial will be performed, in which acupuncture at nonmeridian acupoints and sham AAP will be used as the control group to evaluate the effect of AAP through long-term observation. METHODS: The trial is designed on the basis of the Consolidated Standards of Reporting Trials 2010 guidelines and Standards for Reporting Interventions in Controlled Trials of Acupuncture. A total of 120 participants with perennial allergic rhinitis will be randomly assigned to a treatment or control group. A specially appointed investigator will be in charge of randomization. The participants in the treatment group will be treated with acupuncture at EX-HN3, LI20, and EX-HN8 thrice per week for a total of 12 sessions. In addition, they will undergo AAP at DU14, BL13, EX-BI, and RN22. The participants in the control group will be treated with sham AAP. The primary outcome will be the change in the Total Nasal Symptom Score from baseline to the completion of 4-week treatment. Secondary outcomes include changes in visual analog scale and total non-nasal symptom scores from baseline to the second and fourth weeks of treatment, as well as 1, 3, and 6 months after the completion of treatment. Peripheral blood IL-4, IL-5, IL-6, IL-8, and IL-10 levels will be measured, and any side effects related to treatment will be observed and recorded. DISCUSSION: It is expected that this randomized clinical trial will provide evidence to determine the effects of AAP compared with acupuncture at nonmeridian acupoints and sham AAP, particularly the long-term effect. These findings will help improve the clinical application of this technique. TRIAL REGISTRATION: Acupuncture-Moxibustion Clinical Trial Registry AMCTR-ICR-18000179. Registered on 12 April 2018.
引用
- Shou Y, Hu L, Zhang C, et al. Efficacy of acupuncture at three nasal acupoints plus acupoint application for perennial allergic rhinitis: A multicenter, randomized controlled trial protocol. Trials. 2020. PMID: 31992367. doi:10.1186/s13063-019-4039-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。